Pharmaceutical composition for modified release
US-2024277675-A1 · Aug 22, 2024 · US
US10828289B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10828289-B2 |
| Application number | US-201716327966-A |
| Country | US |
| Kind code | B2 |
| Filing date | Aug 25, 2017 |
| Priority date | Aug 26, 2016 |
| Publication date | Nov 10, 2020 |
| Grant date | Nov 10, 2020 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
There are provided, inter alia, methods and compounds and method for inducing hair growth in a subject in need thereof.
Opening claim text (preview).
What is claimed is: 1. A method for inducing hair growth or inducing hair regeneration in a subject in need thereof, the method comprising administering to the subject an effective amount of a compound of formula (III): wherein: A is CH or N; B is CH or N; and R 10 is halogen, hydrogen, —CX 10.1 3 , —CHX 10.1 2 , —CH 2 X 10.1 , —CN, —SO n1 R 10A , —SO v1 NR 10B R 10C , —NHNR 10B R 10C , —ONR 10B R 10C , —NHC(O)NHNR 10B R 10C , —NHC(O)NR 10B R 10C , —N(O) m1 , —NR 10B R 10C , —C(O)R 10D , —C(O)OR 10D , —C(O)NR 10B R 10C , —OR 10A , —NR 10B SO 2 R 10A , —NR 10B C(O)R 10D , —NR 10B C(O)OR 10D , —NR 10B OR 10D , —OCX 10.1 3 , —OCHX 10.1 2 , substituted or unsubstituted alkyl, substituted or unsubstituted heteroalkyl, substituted or unsubstituted cycloalkyl, substituted or unsubstituted heterocycloalkyl, substituted or unsubstituted aryl, or substituted or unsubstituted heteroaryl; n1 is an integer from 0 to 4; m1 is 1 or 2; v1 is 1 or 2; R 10A , R 10B , R 10C , and R 10D are independently hydrogen, halogen, —CF 3 , —CCl 3 , —CBr 3 , —CI 3 , —OH, —NH 2 , —COOH, —CONH 2 , —NO 2 , —SH, —SO 3 H, —SO 4 H, —SO 2 NH 2 , —NHNH 2 , —ONH 2 , —NHC(O)NHNH 2 , —NHC(O)NH 2 , —NHSO 2 H, —NHC(O)H, —NHC(O)—OH, —NHOH, —OCF 3 , —OCCl 3 , —OCBr 3 , —OCI 3 , —OCHF 2 , —OCHCl 2 , —OCHBr 2 , —OCHI 2 , substituted or unsubstituted alkyl, substituted or unsubstituted heteroalkyl, substituted or unsubstituted cycloalkyl, substituted or unsubstituted heterocycloalkyl, substituted or unsubstituted aryl, or substituted or unsubstituted heteroaryl; R 10B and R 10C substituents bonded to the same nitrogen atom may optionally be joined to form a substituted or unsubstituted heterocycloalkyl or substituted or unsubstituted heteroaryl; and X 10.1 is independently —Cl, —Br, —I or —F. 2. The method of claim 1 , wherein R 10 is halogen. 3. The method of claim 1 , wherein R 10 is fluorine, chlorine, or iodine. 4. The method of claim 1 , wherein the compound of formula (III) is: 5. The method of claim 1 , wherein the compound of formula (III) is: 6. A method for activating a quiescent hair follicle stem cell in a subject in need thereof, the method comprising contacting a quiescent hair follicle stem cell with an effective amount of a compound of formula (III): wherein: A is CH or N; B is CH or N; and R 10 is halogen, hydrogen, —CX 10.1 3 , —CHX 10.1 2 , —CH 2 X 10.1 , —CN, —SO n1 R 10A , —SO v1 NR 10B R 10C , —NHNR 10B R 10C , —ONR 10B R 10C , —NHC(O)NHNR 10B R 10C , —NHC(O)NR 10B R 10C , —N(O) m1 , —NR 10B R 10C , —C(O)R 10D , —C(O)OR 10D , —C(O)NR 10B R 10C , —OR 10A , —NR 10B SO 2 R 10A , —NR 10B C(O)R 10D , —NR 10B C(O)OR 10D , —NR 10B OR 10D , —OCX 10.1 3 , —OCHX 10.1 2 , substituted or unsubstituted alkyl, substituted or unsubstituted heteroalkyl, substituted or unsubstituted cycloalkyl, substituted or unsubstituted heterocycloalkyl, substituted or unsubstituted aryl, or substituted or unsubstituted heteroaryl; n1 is an integer from 0 to 4; m1 is 1 or 2; v1 is 1 or 2; R 10A , R 10B , R 10C , and R 10D are independently hydrogen, halogen, —CF 3 , —CCl 3 , —CBr 3 , —CI 3 , —OH, —NH 2 , —COOH, —CONH 2 , —NO 2 , —SH, —SO 3 H, —SO 4 H, —SO 2 NH 2 , —NHNH 2 , —ONH 2 , —NHC(O)NHNH 2 , —NHC(O)NH 2 , —NHSO 2 H, —NHC(O)H, —NHC(O)—OH, —NHOH, —OCF 3 , —OCCl 3 , —OCBr 3 , —OCI 3 , —OCHF 2 , —OCHCl 2 , —OCHBr 2 , —OCHI 2 , substituted or unsubstituted alkyl, substituted or unsubstituted heteroalkyl, substituted or unsubstituted cycloalkyl, substituted or unsubstituted heterocycloalkyl, substituted or unsubstituted aryl, or substituted or unsubstituted heteroaryl; R 10B and R 10C substituents bonded to the same nitrogen atom may optionally be joined to form a substituted or unsubstituted heterocycloalkyl or substituted or unsubstituted heteroaryl; and X 10.1 is independently —Cl, —Br, —I or —F. 7. The method of claim 6 , wherein the quiescent hair follicle stem cell is a human hair follicle stem cell. 8. The method of claim 6 , wherein the subject is a human subject. 9. The method of claim 6 , wherein R 10 is halogen. 10. The method of claim 6 , wherein R 10 is fluorine, chlorine, or iodine. 11. The method of claim 6 , wherein the compound of formula (III) is: 12. The method of claim 6 , wherein the compound of formula (III) is: 13. A method for inducing glycolysis in a hair follicle stem cell or activating lactate dehydrogenase in a hair follicle stem cell, the method comprising contacting a hair follicle stem cell with an effective amount of a compound of formula (III): wherein: A is CH or N; B is CH or N; and R 10 is halogen, hydrogen, —CX 10.1 3 , —CHX 10.1 2 , —CH 2 X 10.1 , —CN, —SO n1 R 10A , —SO v1 NR 10B R 10C , —NHNR 10B R 10C , —ONR 10B R 10C , —NHC(O)NHNR 10B R 10C , —NHC(O)NR 10B R 10C , —N(O) m1 , —NR 10B R 10C , —C(O)R 10D , —C(O)OR 10D , —C(O)NR 10B R 10C , —OR 10A , —NR 10B SO 2 R 10A , —NR 10B C(O)R 10D , —NR 10B C(O)OR 10D , —NR 10B OR 10D , —OCX 10.1 3 , —OCHX 10.1 2 , substituted or unsubstituted alkyl, substituted or unsubstituted heteroalkyl, substituted or unsubstituted cycloalkyl, substituted or unsubstituted heterocycloalkyl, substituted or unsubstituted aryl, or substituted or unsubstituted heteroaryl; n1 is an integer from 0 to 4; m1 is 1 or 2; v1 is 1 or 2; R 10A , R 10B , R 10C , and R 10D are independently hydrogen, halogen, —CF 3 , —CCl 3 , —CBr 3 , —CI 3 , —OH, —NH 2 , —COOH, —CONH 2 , —NO 2 , —SH, —SO 3 H, —SO 4 H, —SO 2 NH 2 , —NHNH 2 , —ONH 2 , —NHC(O)NHNH 2 , —NHC(O)NH 2 , —NHSO 2 H, —NHC(O)H, —NHC(O)—OH, —NHOH, —OCF 3 , —OCCl 3 , —OCBr 3 , —OCI 3 , —OCHF 2 , —OCHCl 2 , —OCHBr 2 , —OCHI 2 , substituted or unsubstituted alkyl, substituted or unsubstituted heteroalkyl, substituted or unsubstituted cycloalkyl, substituted or unsubstituted heterocycloalkyl, substituted or unsubstituted aryl, or substituted or unsubstituted heteroaryl; R 10B and R 10C substituents bonded to the same nitrogen atom may optionally be joined to form a substituted or unsubstituted heterocycloalkyl or substituted or unsubstituted heteroaryl; and X 10.1 is independently —Cl, —Br, —I or —F. 14. The method of claim 13 , wherein the hair follicle stem cell is a quiescent hair follicle stem cell. 15. The method of claim 13 , wherein a level of a glycolytic metabolite in the hair follicle stem cell is increased relative to the absence of contacting the hair follicle stem cell with the compound of formula (III). 16. The method of claim 15 , wherein the glycolytic metabolite is glucose, fructose-6-phosphate, fructose-bisphosphate, dihydroxyacetone phosphate, 3-phosphoglycerate, lactate, or a combination of two or more thereof. 17. The method of claim 13 , wherein R 10 is halogen. 18. The method of claim 13 , wherein R 10 is fluorine, chlorine, or iodine. 19. The method of claim
of animal origin · CPC title
containing pyrimidine ring derivatives, e.g. minoxidil · CPC title
Preparations for affecting hair growth · CPC title
containing heterocyclic compounds · CPC title
1,3-Thiazoles · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.